Výsledky vyhledávání - Fabrizio Cantini

Upřesnit hledání
  1. 1
    Baricitinib Therapy in Covid-19 Pneumonia — An Unmet Need Fulfilled

    Baricitinib Therapy in Covid-19 Pneumonia — An Unmet Need Fulfilled Autor Delia Goletti, Fabrizio Cantini

    Vydáno 2021
    Získat plný text
    Carta
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Diagnosis of Latent Tuberculosis and Prevention of Reactivation in Rheumatic Patients Receiving Biologic Therapy: International Recommendations

    Diagnosis of Latent Tuberculosis and Prevention of Reactivation in Rheumatic Patients Receiving Biologic Therapy: International Recommendations Autor Florenzo Iannone, Fabrizio Cantini, Giovanni Lapadula

    Vydáno 2014
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Adalimumab, Etanercept, Infliximab, and the Risk of Tuberculosis: Data from Clinical Trials, National Registries, and Postmarketing Surveillance

    Adalimumab, Etanercept, Infliximab, and the Risk of Tuberculosis: Data from Clinical Trials, National Registries, and Postmarketing Surveillance Autor Fabrizio Cantini, Laura Niccoli, Delia Goletti

    Vydáno 2014
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Tuberculosis Risk in Patients Treated with Non-Anti-Tumor Necrosis Factor- (TNF- ) Targeted Biologics and Recently Licensed TNF- Inhibitors: Data from Clinical Trials and National Registries

    Tuberculosis Risk in Patients Treated with Non-Anti-Tumor Necrosis Factor- (TNF- ) Targeted Biologics and Recently Licensed TNF- Inhibitors: Data from Clinical Trials and National... Autor Fabrizio Cantini, Laura Niccoli, Delia Goletti

    Vydáno 2014
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: a long-term follow-up study

    Sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: a long-term follow-up study Autor Fabrizio Cantini, Niccoli Laura, Cassara, Kaloudi, Nannini Carlotta

    Vydáno 2012
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Duration of remission after halving of the etanercept dose in patients with ankylosing spondylitis: a randomized, prospective, long-term, follow-up study

    Duration of remission after halving of the etanercept dose in patients with ankylosing spondylitis: a randomized, prospective, long-term, follow-up study Autor Fabrizio Cantini, Niccoli Laura, Cassara, Kaloudi, Nannini Carlotta

    Vydáno 2013
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  7. 7
    Successful treatment of SAPHO syndrome with infliximab: report of two cases

    Successful treatment of SAPHO syndrome with infliximab: report of two cases Autor Ignazio Olivieri, Angela Padula, Giovanni Ciancìo, Carlo Salvarani, Laura Niccoli, Fabrizio Cantini

    Vydáno 2002
    Získat plný text Získat plný text
    Carta
    Přidat do oblíbených
    Uloženo v:
  8. 8
    Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics

    Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics Autor Fabrizio Cantini, Carlotta Nannini, Laura Niccoli, Linda Petrone, Giuseppe Ippolito, Delia Goletti

    Vydáno 2017
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  9. 9
    Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugs

    Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugs Autor Delia Goletti, Linda Petrone, Giuseppe Ippolito, Laura Niccoli, Carlotta Nannini, Fabrizio Cantini

    Vydáno 2018
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  10. 10
    Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact

    Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact Autor Fabrizio Cantini, Laura Niccoli, Daniela Matarrese, Emanuele Nicastri, Paolo Stobbione, Delia Goletti

    Vydáno 2020
    Získat plný text Získat plný text
    Carta
    Přidat do oblíbených
    Uloženo v:
  11. 11
    Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review

    Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review Autor Fabrizio Cantini, Delia Goletti, Linda Petrone, Saeid Najafi Fard, Laura Niccoli, Rosario Foti

    Vydáno 2020
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  12. 12
    Frequency and duration of clinical remission in patients with peripheral psoriatic arthritis requiring second-line drugs

    Frequency and duration of clinical remission in patients with peripheral psoriatic arthritis requiring second-line drugs Autor Fabrizio Cantini, Laura Niccoli, Carlotta Nannini, Emanuele Cassarà, P. Pasquetti, Ignazio Olivieri, Carlo Salvarani

    Vydáno 2008
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  13. 13
    Immune-Guided Therapy of COVID-19

    Immune-Guided Therapy of COVID-19 Autor Gianfranco Ferraccioli, Elisa Gremese, Delia Goletti, Linda Petrone, Fabrizio Cantini, Stefano Ugel, Stefania Canè, Vincenzo Bronte

    Vydáno 2022
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  14. 14
    HBV Reactivation in Patients Treated with Antitumor Necrosis Factor-Alpha (TNF-<i>α</i>) Agents for Rheumatic and Dermatologic Conditions: A Systematic Review and Meta-Analysis

    HBV Reactivation in Patients Treated with Antitumor Necrosis Factor-Alpha (TNF-<i>α</i>) Agents for Rheumatic and Dermatologic Conditions: A Systematic Review and Meta-Analysis Autor Fabrizio Cantini, Stefania Boccia, Delia Goletti, Florenzo Iannone, Emanuele Leoncini, Nikola Panić, Francesca Prignano, Giovanni Battista Gaeta

    Vydáno 2014
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  15. 15
    Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome: a prospective follow up and magnetic resonance imaging study

    Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome: a prospective follow up and magnetic resonance imaging study Autor Fabrizio Cantini, Carlo Salvarani, Ignazio Olivieri, Libero Barozzi, Luigi Macchioni, Laura Niccoli, Angela Padula, Pietro Pavlica, Luigi Boiardi

    Vydáno 1999
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  16. 16
    Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study

    Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study Autor Laura Niccoli, Carlotta Nannini, Maurizio Benucci, Daniela Chindamo, Emanuele Cassarà, Carlo Salvarani, Luca Cimino, Guido Gini, Ivo Lenzetti, Fabrizio Cantini

    Vydáno 2007
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  17. 17
    ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents)

    ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble i... Autor John W. Baddley, Fabrizio Cantini, Delia Goletti, Juan J. Gómez‐Reino, Eleftherios Mylonakis, Rafael San Juan, Mario Fernández‐Ruiz, Julián Torre‐Cisneros

    Vydáno 2018
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  18. 18
    Cervical interspinous bursitis in active polymyalgia rheumatica

    Cervical interspinous bursitis in active polymyalgia rheumatica Autor Carlo Salvarani, Libero Barozzi, Fabrizio Cantini, Laura Niccoli, Luigi Boiardi, Massimo Valentino, Nicolò Pipitone, Gianluigi Bajocchi, Pierluigi Macchioni, Mariagrazia Catanoso, Ignazio Olivieri, Gene G. Hunder

    Vydáno 2008
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  19. 19
    Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumab

    Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumab Autor Désirée van der Heijde, Maxime Bréban, D Halter, Gino DiVittorio, Johan Bratt, Fabrizio Cantini, S. Kary, Aileen L. Pangan, H. Küpper, Suchitrita S. Rathmann, Joachim Sieper, Phillip J. Mease

    Vydáno 2014
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  20. 20
    The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy

    The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional... Autor Ignazio Olivieri, S De Portu, Carlo Salvarani, Alberto Cauli, Ennio Lubrano, Antonio Spadaro, Fabrizio Cantini, Maria Stefania Cutro, Alessandro Mathieu, Marco Matucci‐Cerinic, N. Pappone, Leonardo Punzi, Raffaele Scarpa, LG Mantovani

    Vydáno 2008
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: